Peel Hunt restated their buy rating on shares of Assura (LON:AGR – Get Rating) in a research report released on Tuesday, Marketbeat Ratings reports. Peel Hunt currently has a GBX 65 ($0.81) price objective on the real estate investment trust’s stock.
Separately, Shore Capital reaffirmed a buy rating on shares of Assura in a research note on Tuesday. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Assura presently has an average rating of Moderate Buy and an average price target of GBX 61.50 ($0.76).
Assura Stock Down 2.2 %
Assura stock opened at GBX 50.25 ($0.63) on Tuesday. The company’s 50 day simple moving average is GBX 50.30 and its 200 day simple moving average is GBX 53. Assura has a fifty-two week low of GBX 46.88 ($0.58) and a fifty-two week high of GBX 72.35 ($0.90). The firm has a market capitalization of £1.49 billion, a price-to-earnings ratio of 1,256.25, a PEG ratio of 3.60 and a beta of 0.27. The company has a debt-to-equity ratio of 70.19, a current ratio of 2.89 and a quick ratio of 2.84.
Assura Increases Dividend
About Assura
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.
See Also
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.